SCHEMBL14033858

SCHEMBL14033858

CC(C)(C)OC(=O)NCCNC(=O)c1cnn2cc(Cc3ccc(Cl)c(Cl)c3)cnc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 3/20 0.42
CSNK1D P48730 1/20 0.41
JAK2 O60674 1/20 0.41
NTRK1 P04629 1/20 0.41
LIPC P11150 1/20 0.37
LIPG Q9Y5X9 1/20 0.37
IRAK4 Q9NWZ3 6/20 0.37
STK17B O94768 1/20 0.37
STK17A Q9UEE5 1/20 0.37
ACVR1B P36896 1/20 0.36
TGFBR1 P36897 1/20 0.36
ACVRL1 P37023 1/20 0.36
CSNK2A2 P19784 1/20 0.36
CSNK2A1 P68400 1/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.35
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033364 0.86 PDE2A (0.44) PDE2ACSNK1DJAK2NTRK1IRAK4
SCHEMBL14048912 0.85 PDE2A (0.44) PDE2ALIPCLIPGIRAK4HSD17B10
SCHEMBL14033688 0.84 PDE2A (0.46) PDE2ALIPCLIPGIRAK4KDM4E
SCHEMBL14032998 0.83 PDE2A (0.43) PDE2AJAK2LIPCLIPGIRAK4
SCHEMBL4555125 0.83 IRAK4 (0.43) PDE2AJAK2NTRK1LIPCLIPG
SCHEMBL4553722 0.83 IRAK4 (0.43) PDE2ALIPCLIPGIRAK4HSD17B10
SCHEMBL14033170 0.83 MAPK1 (0.42) PDE2ANTRK1LIPCLIPGIRAK4
SCHEMBL14033167 0.82 PDE2A (0.41) PDE2ALIPCLIPGIRAK4HSD17B10
SCHEMBL14033330 0.82 PDE2A (0.41) PDE2ALIPCLIPGIRAK4HSD17B10
SCHEMBL14033166 0.81 PDE2A (0.44) PDE2ALIPCLIPGIRAK4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
WO-2008116898-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE BIOVITRUM AB (PUBL) (SE) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255153-A1 New compounds SCD, SCD5, FADS2 PDE2A 2511/4885CSNK1D 1744/4885JAK2 4215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.